MyD88 and TLR9 Dependent Immune Responses Mediate Resistance to Leishmania guyanensis Infections, Irrespective of Leishmania RNA Virus Burden

Protective Immunity to Systemic Infection with Attenuated Salmonella enterica serovar Enteritidis in the Absence of IL-12 Is Associated with IL-23-Dependent IL-22, but Not IL-17

(2014) S. M. Schulz et al.   JOURNAL OF IMMUNOLOGY

Role of Toll-Like Receptor 9 Signaling in Experimental Leishmania braziliensis Infection

(2013) Tiffany Weinkopff et al.   INFECTION AND IMMUNITY

Adjuvants for Leishmania vaccines: from models to clinical application

(2012) Vanitha S. Raman et al.   Frontiers in Immunology

Lymph Node Hypertrophy following Leishmania major Infection Is Dependent on TLR9

(2011) L. P. Carvalho et al.   JOURNAL OF IMMUNOLOGY

Leishmania RNA Virus Controls the Severity of Mucocutaneous Leishmaniasis

(2011) A. Ives et al.   SCIENCE

The MyD88 protein 88 pathway is differently involved in immune responses induced by distinct substrains of Leishmania major

(2010) Mélanie Revaz-Breton et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Use of defined TLR ligands as adjuvants within human vaccines

(2010) Malcolm S. Duthie et al.   IMMUNOLOGICAL REVIEWS

Applying TLR Synergy in Immunotherapy: Implications in Cutaneous Leishmaniasis

(2010) V. S. Raman et al.   JOURNAL OF IMMUNOLOGY

TLR-based immune adjuvants

(2010) Folkert Steinhagen et al.   VACCINE

CXCL10 Production by Human Monocytes in Response to Leishmania braziliensis Infection

(2009) D. A. Vargas-Inchaustegui et al.   INFECTION AND IMMUNITY

Distinct Roles for MyD88 and Toll-Like Receptor 2 during Leishmania braziliensis Infection in Mice

(2009) D. A. Vargas-Inchaustegui et al.   INFECTION AND IMMUNITY